An update from Lucid Diagnostics ( (LUCD) ) is now available.
Lucid Diagnostics Inc. is redeeming its 2023 Convertible Note by issuing new 2024 Convertible Notes to accredited investors, aiming to complete the process within the Optional Redemption Notice Period. These new notes offer a 12% interest rate, a five-year maturity, and conversion options into company stock. Investors are drawn by the secured nature of the notes and the potential for stock conversion, while Lucid ensures the transaction remains exempt from public offering regulations.
See more insights into LUCD stock on TipRanks’ Stock Analysis page.
Trending Articles
- Shareholder Alert for Flux Power Holdings, Inc. (NASDAQ:FLUX)
- ValueAct’s $1B Stake in Meta Platforms is a Constructive Not Activist Bet
- Spirit Airlines Plunges 63% on Possibility of Bankruptcy Deal Wiping Out Shareholders’ Wealth
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
